UBS Group’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
606,664
+190,987
+46% +$530K ﹤0.01% 5157
2025
Q4
$910K Buy
415,677
+10,557
+3% +$26.2K ﹤0.01% 5657
2025
Q3
$948K Sell
405,120
-66,922
-14% -$115K ﹤0.01% 5619
2025
Q2
$718K Sell
472,042
-18,158
-4% -$28.3K ﹤0.01% 5717
2025
Q1
$679K Buy
490,200
+55,643
+13% +$119K ﹤0.01% 5602
2024
Q4
$986K Buy
434,557
+411,783
+1,808% +$1.45M ﹤0.01% 5304
2024
Q3
$107K Sell
22,774
-45,799
-67% -$265K ﹤0.01% 6308
2024
Q2
$513K Sell
68,573
-140,903
-67% -$1.73M ﹤0.01% 4976
2024
Q1
$3.57M Buy
209,476
+70,831
+51% +$1.52M ﹤0.01% 3336
2023
Q4
$3.15M Buy
138,645
+103,662
+296% +$1.74M ﹤0.01% 3307
2023
Q3
$532K Buy
34,983
+20,063
+134% +$274K ﹤0.01% 4598
2023
Q2
$193K Buy
14,920
+13,300
+821% +$144K ﹤0.01% 5505
2023
Q1
$13.4K Buy
1,620
+74
+5% +$693 ﹤0.01% 7398
2022
Q4
$14.3K Sell
1,546
-48,454
-97% -$176K ﹤0.01% 8084
2022
Q3
$33K Buy
+50,000
New +$60.2K ﹤0.01% 6756
2021
Q4
Sell
-964
Closed -$12K 10275
2021
Q3
$12K Buy
964
+741
+332% +$6.83K ﹤0.01% 7745
2021
Q2
$2K Sell
223
-718
-76% -$7.05K ﹤0.01% 8928
2021
Q1
$10K Sell
941
-996
-51% -$12.2K ﹤0.01% 7915
2020
Q4
$24K Buy
1,937
+1,772
+1,074% +$23K ﹤0.01% 6800
2020
Q3
$2K Sell
165
-4,384
-96% -$50.4K ﹤0.01% 7635
2020
Q2
$51K Buy
4,549
+691
+18% +$5.29K ﹤0.01% 5834
2020
Q1
$28K Sell
3,858
-4,184
-52% -$57.4K ﹤0.01% 6261
2019
Q4
$112K Buy
+8,042
New +$95.3K ﹤0.01% 5947

Other funds holding CABA